|
Volumn 90, Issue 4, 2011, Pages 479-481
|
T-cell prolymphocytic leukaemia: Spontaneous immunophenotypical switch from CD4 to CD8 expression
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALEMTUZUMAB;
ASPARAGINASE;
CD2 ANTIGEN;
CD4 ANTIGEN;
CD5 ANTIGEN;
CD7 ANTIGEN;
DEXAMETHASONE;
ETOPOSIDE;
FLUDARABINE;
HEMOGLOBIN;
IFOSFAMIDE;
METHOTREXATE;
MITOXANTRONE;
T LYMPHOCYTE RECEPTOR ALPHA CHAIN;
T LYMPHOCYTE RECEPTOR BETA CHAIN;
ADULT;
BASOPHIL;
BLOOD CELL COUNT;
CASE REPORT;
CD4+ T LYMPHOCYTE;
CD8+ T LYMPHOCYTE;
CHROMOSOME INVERSION;
CHROMOSOME INVERSION 14;
COMBINATION CHEMOTHERAPY;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
IMMUNOPHENOTYPING;
KARYOTYPE;
LETTER;
LEUKOCYTE COUNT;
LUPUS ERYTHEMATOSUS;
LYMPHADENOPATHY;
LYMPHOCYTIC INFILTRATION;
LYMPHOCYTOSIS;
MALE;
MULTIPLE CYCLE TREATMENT;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
PROLYMPHOCYTIC LEUKEMIA;
PROTEIN EXPRESSION;
SKIN BIOPSY;
SPLENECTOMY;
SPLENOMEGALY;
T CELL LEUKEMIA;
T CELL PROLYMPHOCYTIC LEUKEMIA;
THROMBOCYTE COUNT;
TREATMENT DURATION;
TREATMENT RESPONSE;
FATALITY;
IMMUNOLOGY;
MIDDLE AGED;
PATHOLOGY;
CD4-POSITIVE T-LYMPHOCYTES;
CD8-POSITIVE T-LYMPHOCYTES;
FATAL OUTCOME;
HUMANS;
IMMUNOPHENOTYPING;
LEUKEMIA, PROLYMPHOCYTIC, T-CELL;
MALE;
MIDDLE AGED;
|
EID: 79955929947
PISSN: 09395555
EISSN: None
Source Type: Journal
DOI: 10.1007/s00277-010-1026-x Document Type: Letter |
Times cited : (10)
|
References (5)
|